Performance evaluation of a fully automated deep sequencing platform for hepatitis B genotyping and resistance testing
The deep sequencing-based ViroKey® SQ FLEX Genotyping Assay can be confidently used in clinical practice for hepatitis B genotyping and resistance testing.
Authors
- Pierre Cappy (ORCID: https://orcid.org/0000-0001-8540-2196)
- Magali Bouvier‐Alias (ORCID: https://orcid.org/0000-0003-1590-5980)
- Patrick Ingiliz (ORCID: https://orcid.org/0000-0001-7218-4548)
- Jean–Michel Pawlotsky (ORCID: https://orcid.org/0000-0003-0745-7559)
- Valérie Ortonne
- Stéphane Chevaliez (ORCID: https://orcid.org/0000-0001-6913-9017)
- Erwan Vo Quang (ORCID: https://orcid.org/0000-0002-8280-3426)
- Vincent Leroy
Institutions
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Institut Mondor de Recherche Biomédicale (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1093/jac/dkae418
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39